OtherSupplement
A Tabulated Summary of the FDG PET Literature
Sanjiv S. Gambhir, Johannes Czernin, Judy Schwimmer, Daniel H. S. Silverman, R. Edward Coleman and Michael E. Phelps
Journal of Nuclear Medicine May 2001, 42 (5 suppl) 1S-93S;
Sanjiv S. Gambhir
Johannes Czernin
Judy Schwimmer
Daniel H. S. Silverman
R. Edward Coleman
Article Information
vol. 42 no. 5 suppl 1S-93S
PubMed
Published By
Print ISSN
Online ISSN
History
- Published online May 1, 2001.
Copyright & Usage
© 2001
Author Information
Statistics from Altmetric.com
Cited By...
This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.
Article usage
In this issue
A Tabulated Summary of the FDG PET Literature
Sanjiv S. Gambhir, Johannes Czernin, Judy Schwimmer, Daniel H. S. Silverman, R. Edward Coleman, Michael E. Phelps
Journal of Nuclear Medicine May 2001, 42 (5 suppl) 1S-93S;
Jump to section
Related Articles
- No related articles found.
Cited By...
- GOT1 primes the cellular response to hypoxia by supporting glycolysis and HIF1{alpha} stabilisation
- Cancer cells have distinct electrical properties that predict a susceptibility to lipophilic anions; a new cancer drug paradigm
- Quality Improvement Initiatives to Assess and Improve PET/CT Injection Infiltration Rates at Multiple Centers
- Why cancer cells have a more hyperpolarised mitochondrial membrane potential and emergent prospects for therapy
- NADH as a cancer medicine
- The Injustice of Being Judged by the Errors of Others: The Tragic Tale of the Battle for PET Reimbursement
- Harnessing the Power of Molecular Imaging for Precision Medicine
- Detection of Mutant Free Circulating Tumor DNA in the Plasma of Patients with Gastrointestinal Stromal Tumor Harboring Activating Mutations of CKIT or PDGFRA
- Beta-2 Microglobulin as a Diagnostic Parameter in Non-Hodgkin Lymphoma: A Comparative Study with FDG-PET
- Advances in Immuno-Positron Emission Tomography: Antibodies for Molecular Imaging in Oncology
- Immuno-PET of Tissue Factor in Pancreatic Cancer
- Small-Animal PET: What Is It, and Why Do We Need It?
- Recommendations for the use of PET and PET-CT for radiotherapy planning in research projects
- New Pathways to Medicare Coverage for Innovative PET Radiopharmaceuticals: Report of a Medical Imaging & Technology Alliance (MITA) Workshop
- Doing More Harm than Good? Do Systematic Reviews of PET by Health Technology Assessment Agencies Provide an Appraisal of the Evidence That Is Closer to the Truth than the Primary Data Supporting Its Use?
- Positron emission tomography imaging approaches for external beam radiation therapies: current status and future developments
- PET has no clothes
- Imaging Lipid Synthesis in Hepatocellular Carcinoma with [Methyl-11C]Choline: Correlation with In Vivo Metabolic Studies
- Cancer Cell Metabolism
- Uncommon Reason for High Fluorodeoxyglucose Positron Emission Tomography Uptake
- Clinical Value of Fluorine-18 2-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography/Computed Tomography in Bladder Cancer
- Incidental Detection of Acute Lymphoblastic Leukemia on [18F]Fluorodeoxyglucose Positron Emission Tomography
- Long-term Eradication of Locally Recurrent Invasive Follicular Thyroid Carcinoma after Taxane-based Concomitant Chemoradiotherapy
- 18F-FDG PET/CT for Image-Guided and Intensity-Modulated Radiotherapy
- PET and Macro- and Microautoradiographic Studies Combined with Immunohistochemistry for Monitoring Rat Intestinal Ulceration and Healing Processes
- Positron Emission Tomography Imaging of Poststroke Angiogenesis
- Relationship Between Cancer Type and Impact of PET and PET/CT on Intended Management: Findings of the National Oncologic PET Registry
- In Vitro and In Vivo Evaluations of a Hydrophilic 64Cu-Bis(Thiosemicarbazonato)-Glucose Conjugate for Hypoxia Imaging
- Causes and Consequences of Increased Glucose Metabolism of Cancers
- Clinical applications and advances of positron emission tomography with fluorine-18-fluorodeoxyglucose (18F-FDG) in the diagnosis of liver neoplasms
- Impact of Positron Emission Tomography/Computed Tomography and Positron Emission Tomography (PET) Alone on Expected Management of Patients With Cancer: Initial Results From the National Oncologic PET Registry
- 18F-FDG PET for Posttherapy Assessment of Hodgkin's Disease and Aggressive Non-Hodgkin's Lymphoma: A Systematic Review
- Application of PET/CT in the Development of Novel Anticancer Drugs
- Preclinical Efficacy of the c-Met Inhibitor CE-355621 in a U87 MG Mouse Xenograft Model Evaluated by 18F-FDG Small-Animal PET
- 18F-FDG PET/CT in Evaluating Non-CNS Pediatric Malignancies
- Reproducibility of 18F-FDG microPET Studies in Mouse Tumor Xenografts
- Positron emission tomography with computed tomography imaging of neuroinflammation in experimental autoimmune encephalomyelitis
- Improvements in Cancer Staging with PET/CT: Literature-Based Evidence as of September 2006
- Tumor 18F-FDG Incorporation Is Enhanced by Attenuation of P53 Function in Breast Cancer Cells In Vitro
- Procedure Guideline for Tumor Imaging with 18F-FDG PET/CT 1.0
- Comparison of 2-Dimensional and 3-Dimensional Acquisition for 18F-FDG PET Oncology Studies Performed on an LSO-Based Scanner
- In vivo positron-emission tomography imaging of progression and transformation in a mouse model of mammary neoplasia
- Impact of Patient Weight and Emission Scan Duration on PET/CT Image Quality and Lesion Detectability
- Impact of Whole-Body 18F-FDG PET on Staging and Managing Patients for Radiation Therapy
- Functional imaging for assessment of therapy
- Role of 18F-FDG Dual-Head Gamma-Camera Coincidence Imaging in Recurrent or Metastatic Colorectal Carcinoma